2023
DOI: 10.1016/j.ijpddr.2022.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Effect of geranylated dihydrochalcone from Artocarpus altilis leaves extract on Plasmodium falciparum ultrastructural changes and mitochondrial malate: Quinone oxidoreductase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…In general, there are a variety of potent inhibitors, all of which bind to the quinone reaction site in a variety of oxidoreductases that use quinones as substrates. This implies that the quinone-binding site is a possible druggable site in MQO. Using several approaches including drug screening, compounds have been identified that might inhibit MQO. ,,, However, to the best of our knowledge, no inhibitor has been yet reported that interacts with the quinone-binding site. To explore novel inhibitors targeting MQO, it will be necessary to fully understand the mechanism of action of MQO, for example, by solving the structure of enzyme–substrate complexes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, there are a variety of potent inhibitors, all of which bind to the quinone reaction site in a variety of oxidoreductases that use quinones as substrates. This implies that the quinone-binding site is a possible druggable site in MQO. Using several approaches including drug screening, compounds have been identified that might inhibit MQO. ,,, However, to the best of our knowledge, no inhibitor has been yet reported that interacts with the quinone-binding site. To explore novel inhibitors targeting MQO, it will be necessary to fully understand the mechanism of action of MQO, for example, by solving the structure of enzyme–substrate complexes.…”
Section: Discussionmentioning
confidence: 99%
“…Using several approaches including drug screening, compounds have been identified that might inhibit MQO. 12 , 14 , 49 , 50 However, to the best of our knowledge, no inhibitor has been yet reported that interacts with the quinone-binding site. To explore novel inhibitors targeting MQO, it will be necessary to fully understand the mechanism of action of MQO, for example, by solving the structure of enzyme–substrate complexes.…”
Section: Discussionmentioning
confidence: 99%
“…AAL.E.2 isolated 1-(2,4-dihydroxy phenyl)-3-[8-hydroxy-2methyl-2-(4-methyl-3-pentenyl)-2H-1-benzopyran-5yl]-1-propanone, and AAL.E.4 isolated geranyl-2′, 4 ′, 3, 4-tetrahydroxy-dihydrochalcone. Both inhibit P. falciparum and PfMQO enzymes (Hidayati et al, 2023). Further studies are needed on fraction 5 (AAL.E.5) to determine the active substance that acts as an antimalarial agent.…”
Section: Introductionmentioning
confidence: 99%